4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-044630
President, R&D sold 11,043 shares at $2.06 ($22,749)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Amado Rafael President, R&D | 2019-08-06 | Sale | −11,043 | $2.06 | $22,749 | 17,237 | D |
| Open-market sales · 11,043 sh · avg $2.06 · $22,749 | |||||||
Loading xslF345X03/a4.xml…